These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31923313)

  • 1. How much can acute heart failure patients with low basic blood pressure (systolic blood pressure 90-100 mmHg) benefit from the use of vasodilators?
    Zhou Y; Wen J; Nie J
    Eur Heart J; 2020 Mar; 41(12):1307-1308. PubMed ID: 31923313
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous vasodilators in acute heart failure patients with low basic blood pressure: may the benefit come from targeting perfusion rather than pressure?
    Bocchino PP; Angelini F; Frea S
    Eur Heart J; 2020 Jul; 41(25):2409-2410. PubMed ID: 32556107
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanism of action and clinical use of vasodilators in acute heart insufficiency].
    Rothlin ME
    Schweiz Rundsch Med Prax; 1985 Dec; 74(49):1372-5. PubMed ID: 4081449
    [No Abstract]   [Full Text] [Related]  

  • 4. Rationale and use of vasodilators in the management of congestive heart failure.
    Lakier JB; Khaja F; Stein PD
    Am Heart J; 1979 Apr; 97(4):519-26. PubMed ID: 371379
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic use of vasodilators in congestive cardiac insufficiency].
    Quesada Vargas O
    Cardiology; 1980; 66 Suppl 2():169-76. PubMed ID: 7285027
    [No Abstract]   [Full Text] [Related]  

  • 6. Early Blood Pressure Reduction by Intravenous Vasodilators Is Associated With Acute Kidney Injury in Patients With Hypertensive Acute Decompensated Heart.
    Arao Y; Sawamura A; Nakatochi M; Okumura T; Kato H; Oishi H; Yamaguchi S; Haga T; Kuwayama T; Yokoi T; Hiraiwa H; Kondo T; Morimoto R; Murohara T
    Circ J; 2019 Aug; 83(9):1883-1890. PubMed ID: 31316033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Vasodilators and Sympatholytic Agents.
    McComb MN; Chao JY; Ng TM
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):3-19. PubMed ID: 26033778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilators have not been shown to be of value in all patients with chronic congestive heart failure due to left ventricular systolic dysfunction.
    Kulick DL; Rahimtoola SH
    Am J Cardiol; 1990 Aug; 66(4):435-8. PubMed ID: 2201177
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure.
    Franciosa JA; Cohn JN
    Am J Med; 1978 Jul; 65(1):126-33. PubMed ID: 685986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.
    Prescrire Int; 2011 Jun; 20(117):156-60. PubMed ID: 21678708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure.
    Ishihara S; Gayat E; Sato N; Arrigo M; Laribi S; Legrand M; Placido R; Manivet P; Cohen-Solal A; Abraham WT; Jessup M; Mebazaa A
    Clin Res Cardiol; 2016 Dec; 105(12):971-980. PubMed ID: 27314418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
    Kodama K; Koretsune Y; Nanto S; Taniura K
    Jpn Circ J; 1984 Apr; 48(4):380-7. PubMed ID: 6425527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilators.
    Zsotér TT
    Can Med Assoc J; 1983 Sep; 129(5):424-8, 432. PubMed ID: 6349763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of nitroglycerin for injection in comparison with other vasodilators in the treatment of cardiac failure of ischemic origin].
    Francoual M
    Nouv Presse Med; 1979 Jan; 8(4):293-6. PubMed ID: 122024
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current aspects of drug treatment of patients with congestive heart failure].
    Bertel O
    Schweiz Med Wochenschr; 1983 May; 113(20):739-45. PubMed ID: 6410501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilators in the treatment of heart failure.
    Mehta J
    JAMA; 1977 Dec; 238(23):2534-6. PubMed ID: 578895
    [No Abstract]   [Full Text] [Related]  

  • 17. Paradoxical hypertension after reversal of heart failure in patients treated with intensive vasodilator therapy.
    Levine TB; Levine AB; Kathawala M; Narins B; Kaminski P
    Am J Hypertens; 1998 Sep; 11(9):1041-7. PubMed ID: 9752888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Organic nitrate and vasodilator therapy of cardiac insufficiency].
    Strauer BE
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():154-70. PubMed ID: 417497
    [No Abstract]   [Full Text] [Related]  

  • 19. [The treatment of congestive heart failure by using vasodilators. I. Physiological basis. Different vasodilators (author's transl)].
    Solignac A
    Nouv Presse Med; 1978 Mar; 7(12):1013-20. PubMed ID: 96422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure.
    Wilson RM; De Silva DS; Sato K; Izumiya Y; Sam F
    Hypertension; 2009 Sep; 54(3):583-90. PubMed ID: 19620510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.